# An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

> **NCT01344902** · PHASE1,PHASE2 · TERMINATED · sponsor: **Photocure** · enrollment: 13 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** hexaminolevulinate HCl

## Key facts

- **NCT ID:** NCT01344902
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2009-10
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The study was stopped due to inadequate efficacy after 13 patients were evaluated.
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344902, "An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01344902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*